Paper6443765
Epidemiology of infections due to Pseudomonas aeruginosa.
Morrison AJ and 1 other. Rev Infect Dis, 1984. Cited by 197 papers, by iCite.
Cite this record
ConductScience Library. Epidemiology of infections due to Pseudomonas aeruginosa. Papers, record 6443765. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/6443765
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics6
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cross Infection | Major topic |
| Pseudomonas Infections | Major topic |
| Pseudomonas aeruginosa | Major topic |
| Disease Outbreaks | |
| Humans | |
| Risk |
Source PubMed
Cited by78
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 197 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42029769 | Pseudomonas aeruginosa: associated pathogenesis, epidemiology, resistance mechanisms, host response and emerging treatment strategies. | Arch Microbiol | 2026 | https://conductscience.org/library/papers/42029769 | PubMed |
| 41616246 | The Pseudomonas aeruginosa PrrF sRNAs and PqsA promote biofilm formation at body temperature. | J Bacteriol | 2026 | https://conductscience.org/library/papers/41616246 | PubMed |
| 41312397 | Genomic characterization of cefotaxime-resistant Proteobacteria isolated from a bat-harboring cave in Zambia. | New Microbes New Infect | 2025 | https://conductscience.org/library/papers/41312397 | PubMed |
| 40313230 | Moving Beyond the Silos of Opportunistic Pathogen and Disinfection Byproduct Research to Improve Drinking Water System Management. | Environ Sci Technol | 2025 | https://conductscience.org/library/papers/40313230 | PubMed |
| 40227851 | Distinct antibiotic treatment regimens differentially affect colonization resistance against multi-drug resistant Pseudomonas aeruginosa in mice. | Eur J Microbiol Immunol (Bp) | 2025 | https://conductscience.org/library/papers/40227851 | PubMed |
| 40062881 | Sphingosine-mediated death of Pseudomonas aeruginosa involves degradation of cardiolipin by the maintenance of outer lipid asymmetry system. | Infect Immun | 2025 | https://conductscience.org/library/papers/40062881 | PubMed |
| 40006944 | New Bacteriophage Pseudomonas Phage Ka2 from a Tributary Stream of Lake Baikal. | Viruses | 2025 | https://conductscience.org/library/papers/40006944 | PubMed |
| 38436566 | Flip the switch: the role of FleQ in modulating the transition between the free-living and sessile mode of growth in Pseudomonas aeruginosa. | J Bacteriol | 2024 | https://conductscience.org/library/papers/38436566 | PubMed |
| 37884397 | Pseudomonas aeruginosa biofilm exopolysaccharides: assembly, function, and degradation. | FEMS Microbiol Rev | 2023 | https://conductscience.org/library/papers/37884397 | PubMed |
| 37656255 | Comparative bacteriome and antibiotic resistome analysis of water and sediment of the Ganga River of India. | World J Microbiol Biotechnol | 2023 | https://conductscience.org/library/papers/37656255 | PubMed |
| 36611992 | Pseudomonas aeruginosa: Infections, Animal Modeling, and Therapeutics. | Cells | 2023 | https://conductscience.org/library/papers/36611992 | PubMed |
| 35040024 | Antimicrobial Peptides from Human Microbiome Against Multidrug Efflux Pump of Pseudomonas aeruginosa: a Computational Study. | Probiotics Antimicrob Proteins | 2022 | https://conductscience.org/library/papers/35040024 | PubMed |
| 34703170 | Distribution of Class 1-3 Integrons in Carbapenem-Resistant Pseudomonas aeruginosa Isolated from Inpatients in Shiraz, South of Iran. | Ethiop J Health Sci | 2021 | https://conductscience.org/library/papers/34703170 | PubMed |
| 34680745 | Pseudomonas aeruginosa mexR and mexEF Antibiotic Efflux Pump Variants Exhibit Increased Virulence. | Antibiotics (Basel) | 2021 | https://conductscience.org/library/papers/34680745 | PubMed |
| 34064516 | The Anti-Infectious Role of Sphingosine in Microbial Diseases. | Cells | 2021 | https://conductscience.org/library/papers/34064516 | PubMed |
| 32793169 | Comparison of Whole Genome (wg-) and Core Genome (cg-) MLST (BioNumericsTM) Versus SNP Variant Calling for Epidemiological Investigation of Pseudomonas aeruginosa. | Front Microbiol | 2020 | https://conductscience.org/library/papers/32793169 | PubMed |
| 32542137 | Prevalence and Possible Predictors of Drug-Resistant Pseudomonas aeruginosa in External Ocular Infections: A Single-Center, Retrospective, Cross-Sectional Study. | Cureus | 2020 | https://conductscience.org/library/papers/32542137 | PubMed |
| 32327486 | Sphingosine kills bacteria by binding to cardiolipin. | J Biol Chem | 2020 | https://conductscience.org/library/papers/32327486 | PubMed |
| 32131866 | Efficacy, immunogenicity, and safety of IC43 recombinant Pseudomonas aeruginosa vaccine in mechanically ventilated intensive care patients-a randomized clinical trial. | Crit Care | 2020 | https://conductscience.org/library/papers/32131866 | PubMed |
| 32047733 | Combining Standard Molecular Typing and Whole Genome Sequencing to Investigate Pseudomonas aeruginosa Epidemiology in Intensive Care Units. | Front Public Health | 2020 | https://conductscience.org/library/papers/32047733 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/6443765
GET https://conductscience.org/api/papers/v1/6443765/cited_by?page=2